Welcome to the web pages of Harald Stenmark's group
Our group studies the molecular mechanisms that promote or suppress cancer, a disease that involves uncontrolled proliferation and invasiveness of specific cell types of the body. A description of our research can be found here.
Our group is member of a Centre of Excellence, Centre for Cancer Biomedicine (CCB), and a Centre for Research Based Innovation, Cancer Stem Cell Innovation Centre (CAST). We are also member of the NordForsk network on cilia and centrosomes and the NordForsk network on autophagy.
Department of Biochemistry, Institute for Cancer Research
The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway
Telephone +47 22 78 18 18 (Stenmark), +47 22 78 12 69 (Dept. Secretary)
Email: stenmark@ulrik.uio.no
Print this page [30150 visits]Latest publications
Harald Stenmark's group
Selective autophagy in Drosophila
Int J Cell Biol, 2012, 146767
PubMed 22567011
The RING-type ubiquitin ligases Pex2p, Pex10p and Pex12p form a heteromeric complex that displays enhanced activity in an ubiquitin conjugating enzyme-selective manner
FEBS J, 279 (11), 2060-70
PubMed 22471590
A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice
Cancer Res (in press)
PubMed 22440753
